Frontier Capital Management CO LLC Axsome Therapeutics, Inc. Transaction History
Frontier Capital Management CO LLC
- $9.96 Billion
- Q3 2024
A detailed history of Frontier Capital Management CO LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Frontier Capital Management CO LLC holds 120,540 shares of AXSM stock, worth $10.9 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
120,540
Previous 96,027
25.53%
Holding current value
$10.9 Million
Previous $7.73 Million
40.1%
% of portfolio
0.11%
Previous 0.08%
Shares
8 transactions
Others Institutions Holding AXSM
# of Institutions
325Shares Held
37.7MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$380 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$362 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$299 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$214 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$94.9 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.89B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...